Name That Brand: April 2012

Share this article:

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, along with clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Ave 2: The Story of Medical Advertising in America 1990-2008. E-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is April 30, 2012. The winner will be picked randomly from the correct entries.

Brand X puts its best feet forward
This first-to-market drug earned its manufacturer roughly $2 billion in revenues last year. Initially approved in 2003 to treat a befuddling, nebulous condition, it has expanded to include at least four others. While the conditions the drug treats have names and treatment plans, just how it quiets the symptoms is a mystery. This spot is just one take on evoking a patient's frame of mind; the brand has also used of portraits and lifestyle shots that highlight the mental and physical toll of this painful condition.

FEBRUARY'S WINNER...
Congratulations to Carly Kuper, VP, Strategic Marketing & Corporate Communications at CMI Communications Media Inc., who correctly guessed Nicorette, Glaxo­SmithKline's product to help cigarette smokers quit.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"